M BIO TECHNOLOGY, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2013/0217,031 GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAEDec 28, 12Aug 22, 13[C07H, G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9539209 Vaccine for mycoplasma infectionJun 04, 10Jan 10, 17[A61K]
8367076 English Title Not AvailableJun 13, 07Feb 05, 13[A61K]
5994090 Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasmaDec 03, 96Nov 30, 99[A61K, C07H, C12Q, G01N]
5498527 Phosphorylcholine-containing glyceroglycolipidMay 31, 94Mar 12, 96[C12Q, C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
6376203 Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasmaExpiredJul 08, 99Apr 23, 02[A61K, C07H, C12Q, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.